Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma

Clinical trial NCT03389230 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03389230
Sponsor: City of Hope Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma Malignant Glioma Recurrent Glioma Refractory Glioma WHO Grade III Glioma

Start date: 2018-08-14
Primary completion: 2026-12-29
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.